Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: Relationship to bone parameters

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1243-1249

  Edouard, Thomas ^a,b   Husseini, Abdallah ^a   Glorieux, Francis H ^a   Rauch, Frank ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYVITAMIN D; AMINO TERMINAL TELOPEPTIDE; CALCIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ARTICLE; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CHILD; CLINICAL EVALUATION; DISEASE SEVERITY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOGENESIS IMPERFECTA; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; VITAMIN BLOOD LEVEL;

24,25-DIHYDROXYVITAMIN D 3; 25-HYDROXYVITAMIN D 2; ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CALCIFEDIOL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ERGOCALCIFEROLS; FEMALE; HUMANS; INFANT; MALE; OSTEOGENESIS IMPERFECTA; PARATHYROID HORMONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84859544312     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3015     Document Type: Article

References (40)

1. Bikle DD 2010 Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 21:375-384
2. St-Arnaud R 2011 CYP24A1: structure, function, and physiological role. In: Feldman D, Pike JW, Adams JS, eds. Vitamin D. 3rd ed. San Diego: Elsevier; 43-56
3. Wagner D, Hanwell HE, Schnabl K, Yazdanpanah M, Kimball S, Fu L, Sidhom G, Rousseau D, Cole DE, Vieth R 2011 The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation. J Steroid Biochem Mol Biol 126:72-77
4. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Bröking E, Fehrenbach H, Wingen AM, Güran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M 2011 Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365:410-421
5. Dauber A, Nguyen TT, Sochett E, Cole DE, Horst R, Abrams SA, Carpenter TO, Hirschhorn JN 23 November 2011 Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab doi: 10.1210/jc.2011-1972
6. Jarnagin K, Brommage R, DeLuca HF, Yamada S, Takayama H 1983 1- but not 24-hydroxylation of vitamin D is required for growth and reproduction in rats. Am J Physiol 244:E290-E297 (Pubitemid 13112425)
7. Ameenuddin S, Sunde M, DeLuca HF, Ikekawa N, Kobayashi Y 1982 24-Hydroxylation of 25-hydroxyvitamin D3: is it required for embryonic development in chicks? Science 217:451-452 (Pubitemid 12048297)
8. Tanaka Y, DeLuca HF, Kobayashi Y, Taguchi T, Ikekawa N, Morisaki M 1979 Biological activity of 24,24-difluoro-25-hydroxyvitamin D3. Effect of blocking of 24-hydroxylation on the functions of vitamin D. J Biol Chem 254:7163-7167 (Pubitemid 9243569)
9. Norman AW, Henry HL, Malluche HH 1980 24R,25-Dihydroxyvitamin D3 and 1 α,25-dihydroxyvitamin D3 are both indispensable for calcium and phosphorus homeostasis. Life Sci 27:229-237 (Pubitemid 11238118)
10. Schwartz Z, Boyan B 1988 The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro. Endocrinology 122:2191-2198
11. Pedrozo HA, Schwartz Z, Mokeyev T, Ornoy A, Xin-Sheng W, Bonewald LF, Dean DD, Boyan BD 1999 Vitamin D3 metabolites regulate LTBP1 and latent TGF-β1 expression and latent TGF-β1 incorporation in the extracellular matrix of chondrocytes. J Cell Biochem 72:151-165 (Pubitemid 28541490)
12. Endo H, Kiyoki M, Kawashima K, Naruchi T, Hashimoto Y 1980 Vitamin D3 metabolites and PTH synergistically stimulate bone formation of chick embryonic femur in vitro. Nature 286:262-264 (Pubitemid 10009984)
13. Galus K, Szymendera J, Zaleski A, Schreyer K 1980 Effects of 1 α-hydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on bone remodeling. Calcif Tissue Int 31:209-213 (Pubitemid 10023266)
14. St-Arnaud R 2010 CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J Steroid Biochem Mol Biol 121:254-256
15. Carpenter TO, Keller M, Schwartz D, Mitnick M, Smith C, Ellison A, Carey D, Comite F, Horst R, Travers R, Glorieux FH, Gundberg CM, Poole AR, Insogna KL 1996 24,25-Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets-a clinical research center study. J Clin Endocrinol Metab 81:2381-2388 (Pubitemid 26175972)
16. Birkenhäger-Frenkel DH, Pols HA, Zeelenberg J, Eijgelsheim JJ, Schot R, Nigg AL, Weimar W, Mulder PG, Birkenhäger JC 1995 Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 α-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. J Bone Miner Res 10:197-204
17. Nakamura T, Kurokawa T, OrimoH1988 Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3. Calcif Tissue Int 43:235-243
18. Nakamura T, Suzuki K, Hirai T, Kurokawa T, Orimo H 1992 Increased bone volume and reduced bone turnover in vitamin D-replete rabbits by the administration of 24R,25-dihydroxyvitamin D3. Bone 13:229-236
19. Ono T, Tanaka H, Yamate T, Nagai Y, Nakamura T, Seino Y 1996 24R,25-Dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice. Endocrinology 137:2633-2637 (Pubitemid 26155801)
20. Rauch F, Glorieux FH 2004 Osteogenesis imperfecta. Lancet 363: 1377-1385 (Pubitemid 38529880)
21. Sillence DO, Senn A, Danks DM 1979 Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101-116 (Pubitemid 9164903)
22. Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH 2003 Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 88:986-992 (Pubitemid 36337744)
23. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer- Strawn LM, Curtin LR, Roche AF, Johnson CL 2002 Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60
24. Haddad Jr JG, Min C, Mendelsohn M, Slatopolsky E, Hahn TJ 1977 Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects. Arch Biochem Biophys 182:390-395 (Pubitemid 8161047)
25. Holick MF 2009 Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19:73-78
26. Bollen AM, Eyre DR 1994 Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 15:31-34 (Pubitemid 24107939)
27. Salle BL, Braillon P, Glorieux FH, Brunet J, Cavero E, Meunier PJ 1992 Lumbar bone mineral content measured by dual energy x-ray absorptiometry in newborns and infants. Acta Paediatr 81:953-958 (Pubitemid 23044765)
28. Zeitlin L, Rauch F, Plotkin H, Glorieux FH 2003 Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111:1030-1036 (Pubitemid 36542617)
29. Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P 2007 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103:204-205 (Pubitemid 46420528)
30. Edouard T, Glorieux FH, Rauch F 2011 Predictors and correlates of vitamin D status in children and adolescents with osteogenesis imperfecta. J Clin Endocrinol Metab 96:3193-3198
31. Seo EG, Einhorn TA, Norman AW 1997 24R,25-Dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 138: 3864-3872 (Pubitemid 27351941)
32. Seo EG, Norman AW 1997 Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. J Bone Miner Res 12:598-606 (Pubitemid 27155219)
33. Schoenmakers I, Ginty F, Jarjou LM, Nigdikar S, Bennett J, Laidlaw A, Prentice A 2010 Interrelation of parathyroid hormone and vitamin D metabolites in adolescents from the UK and The Gambia. J Steroid Biochem Mol Biol 121:217-220
34. Aksnes L, Aarskog D 1982 Plasma concentrations of vitamin D metabolites in puberty: effect of sexual maturation and implications for growth. J Clin Endocrinol Metab 55:94-101 (Pubitemid 13250331)
35. Orwoll ES, Meier DE 1986 Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. J Clin Endocrinol Metab 63:1262-1269 (Pubitemid 17206416)
36. Petkovich M, Jones G 2011 CYP24A1 and kidney disease. Curr Opin Nephrol Hypertens 20:337-344
37. Armbrecht HJ, Hodam TL, Boltz MA, Partridge NC, Brown AJ, Kumar VB 1998 Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells. Endocrinology 139:3375-3381 (Pubitemid 28512291)
38. van Leeuwen JP, Birkenhäger JC, van den Bemd GC, Pols HA 1996 Evidence for coordinated regulation of osteoblast function by 1,25- dihydroxyvitamin D3 and parathyroid hormone. Biochim Biophys Acta 1312:54-62
39. Yamamoto T, Ozono K, Shima M, Yamaoka K, Okada S 1998 24R,25-Dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells. Exp Cell Res 244: 71-76 (Pubitemid 28480855)
40. Riis BJ, Thomsen K, Christiansen C 1986 Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss? Calcif Tissue Int 39: 128-132 (Pubitemid 16039682)